Content Details
Information on this page was last modified on : 2021/04/29 3:13:06 PM

Pyrolate Injection 0.2 mg 10 Ampx1 mL

Belongs to Category,

Pyrolate Injection contains Glycopyrrolate | belongs to Antimuscarinic

Alternate brands of Pyrolate Injection 0.2 mg 10 Ampx1 mL

Brand Name Price Savings
Glycol-P Injection 0.2 mg 10 Ampx1 mL  115.00 You can save 56.93
List of alternate brands

How it works

Pyrolate Injection 0.2 mg 10 Ampx1 mL decreases stomach acid and saliva production by blocking the activity of a certain natural substance in the body.


Frequently asked questions

  • Onset of action

  • Duration of Effect

  • Safe with Alchohol?

  • Is it habit forming?

  • Usage in pregnancy?

  • Usage while breast-feeding?


  • Missed Dose

  • Overdose


Additional Information:

How to use Pyrolate Injection 0.2 mg 10 Ampx1 mL

Administer IV at a rate of 0.2 mg over 1-2 min. May be administered IV or IM without dilution. May also be administered via the tubing of a running IV infusion of a compatible solution. May be administered IV in the same syringe with neostigmine or pyridostigmine.
Stability: Store at 20°C-25°C.
Compatibility: Do not mix glycopyrrolate with alkaline drugs or solutions that have a pH over 6.0 because drug stability may be affected. A pH over 6.0 may occur if glycopyrrolate is mixed with dexamethasone sodium phosphate or LR solution. Gas or precipitate may form if glycopyrrolate is mixed in same syringe as chloramphenicol, diazepam, dimenhydrinate, methohexital sodium, pentobarbital sodium, secobarbital sodium, sodium bicarbonate, or thiopental sodium.

Children: Control of upper airways secretion and hypersalivation: Oral: 1 mth-18 yr, 40-100 mcg/kg, max 2 mg, 3-4 times daily, adjusted according to response. SC infusion: 1 mth-12 yr, 12-40 mcg/kg/24 hr, max 1.2 mg; 12-18 yr, 0.6-1.2 mg/24 hr. SC injection or IM or IV injection: 1 mth-12 yr, 4-10 mcg/kg, max 200 mcg, 4 times a day when required; 12-18 yr, 200 mcg every 4 hr when required.

what are the adverse effects of Pyrolate Injection 0.2 mg 10 Ampx1 mL?

Dry skin. Constipation, dry throat, dry mouth. Irritation at injection site. Dry nose. Diaphoresis (decreased).

What happens if I miss a dose of Pyrolate Injection 0.2 mg 10 Ampx1 mL?

Adults: INJECTION: Control of secretions: Intra-operative: IV: 0.1 mg repeated as needed at 2-3 mins intervals. Preoperative: IM: 4.4 mcg/kg 30-60 min before procedure.
Reverse neuromuscular blockade: IV: 0.2 mg for each 1 mg of neostigmine or 5 mg of pyridostigmine administered or 5-15 mcg/kg glycopyrrolate with 25-70 mcg/kg of neostigmine or 0.1-0.3 mg/kg of pyridostigmine (agents usually administered simultaneously, but glycopyrrolate may be administered first if bradycardia is present).
Peptic ulcer: IM/IV: 0.1-0.2 mg 3-4 times/day.
Adults: ORAL: Peptic ulcer: 1-2 mg 2-3 times daily.
Children: INJECTION: Premedication at induction: IV or IM injection: Neonate, 5 mcg/kg; 1 mth-12 yr, 4-8 mcg/kg, max 200 mcg; 12-18 yr, 200-400 mcg or 4-5 mcg/kg, max 400 mcg.
Intra-operative bradycardia: IV injection: Neonate, 10 mcg/kg, repeated if necessary; 1 mth-18 yr, 4-8 mcg/kg, max 200 mcg, repeated if necessary.
Control of muscarinic side-effects of neostigmine in reversal of competitive neuromuscular block: IV injection: Neonate, 10 mcg/kg; 1 mth-12 yr, 10 mcg/kg, max 500 mcg; 12-18 yr, 200 mcg per 1 mg of neostigmine, or 10-15 mcg/kg.

One of the following licensed pharmacy from the nearest location will deliver Pyrolate Injection 0.2 mg 10 Ampx1 mL. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions


There are no reviews yet.

Be the first to review “Pyrolate Injection 0.2 mg 10 Ampx1 mL”
Shopping Cart